News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
629,685 Results
Type
Article (49748)
Company Profile (145)
Press Release (579792)
Multimedia
Podcasts (102)
Webinars (13)
Section
Business (180567)
Career Advice (1988)
Deals (29642)
Drug Delivery (113)
Drug Development (81486)
Employer Resources (123)
FDA (16813)
Job Trends (12850)
News (316985)
Policy (33136)
Tag
Academia (2470)
Academic (2)
Accelerated approval (6)
Adcomms (28)
Allergies (83)
Alliances (47917)
ALS (97)
Alzheimer's disease (1428)
Antibody-drug conjugate (ADC) (156)
Approvals (16792)
Artificial intelligence (272)
Autoimmune disease (26)
Automation (14)
Bankruptcy (261)
Best Places to Work (10000)
BIOSECURE Act (21)
Biosimilars (111)
Biotechnology (104)
Bladder cancer (81)
Brain cancer (30)
Breast cancer (282)
Cancer (2279)
Cardiovascular disease (185)
Career advice (1685)
Career pathing (29)
CAR-T (146)
Cell therapy (424)
Cervical cancer (19)
Clinical research (66285)
Collaboration (860)
Compensation (368)
Complete response letters (28)
COVID-19 (2503)
CRISPR (39)
C-suite (229)
Cystic fibrosis (101)
Data (2177)
Decentralized trials (2)
Denatured (32)
Depression (51)
Diabetes (284)
Diagnostics (5413)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (39)
Drug discovery (139)
Drug pricing (122)
Drug shortages (33)
Duchenne muscular dystrophy (95)
Earnings (71997)
Editorial (42)
Employer branding (16)
Employer resources (110)
Events (94895)
Executive appointments (694)
FDA (18086)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (7)
Funding (714)
Gene editing (98)
Generative AI (26)
Gene therapy (311)
GLP-1 (800)
Government (4332)
Grass and pollen (4)
Guidances (56)
Healthcare (16151)
Huntington's disease (21)
IgA nephropathy (30)
Immunology and inflammation (130)
Indications (30)
Infectious disease (2638)
Inflammatory bowel disease (144)
Inflation Reduction Act (11)
Influenza (47)
Intellectual property (100)
Interviews (365)
IPO (13332)
IRA (51)
Job creations (3269)
Job search strategy (1421)
Kidney cancer (11)
Labor market (26)
Layoffs (468)
Leadership (19)
Legal (7597)
Liver cancer (77)
Lung cancer (325)
Lymphoma (155)
Machine learning (6)
Management (40)
Manufacturing (304)
MASH (71)
Medical device (10894)
Medtech (10899)
Mergers & acquisitions (16846)
Metabolic disorders (742)
Multiple sclerosis (86)
NASH (20)
Neurodegenerative disease (109)
Neuropsychiatric disorders (31)
Neuroscience (2003)
NextGen: Class of 2025 (5470)
Non-profit (3895)
Now hiring (23)
Obesity (401)
Opinion (263)
Ovarian cancer (70)
Pain (90)
Pancreatic cancer (79)
Parkinson's disease (155)
Partnered (17)
Patents (228)
Patient recruitment (107)
Peanut (44)
People (51962)
Pharmaceutical (38)
Pharmacy benefit managers (20)
Phase I (20222)
Phase II (28671)
Phase III (22295)
Pipeline (1180)
Policy (162)
Postmarket research (3133)
Preclinical (8715)
Press Release (67)
Prostate cancer (110)
Psychedelics (37)
Radiopharmaceuticals (248)
Rare diseases (391)
Real estate (4885)
Recruiting (47)
Regulatory (23400)
Reports (31)
Research institute (2271)
Resumes & cover letters (303)
Rett syndrome (5)
RNA editing (5)
RSV (38)
Schizophrenia (77)
Series A (130)
Series B (77)
Service/supplier (9)
Sickle cell disease (51)
Special edition (17)
Spinal muscular atrophy (159)
Sponsored (26)
Startups (3221)
State (2)
Stomach cancer (15)
Supply chain (68)
Tariffs (42)
The Weekly (68)
Vaccines (674)
Venture capitalists (33)
Weight loss (287)
Women's health (30)
Worklife (14)
Date
Today (162)
Last 7 days (835)
Last 30 days (2571)
Last 365 days (31143)
2025 (10363)
2024 (32886)
2023 (36576)
2022 (47125)
2021 (50262)
2020 (48079)
2019 (41023)
2018 (31067)
2017 (30363)
2016 (29510)
2015 (33906)
2014 (27838)
2013 (23896)
2012 (25069)
2011 (25505)
2010 (24302)
Location
Africa (827)
Alabama (56)
Alaska (6)
Arizona (155)
Arkansas (13)
Asia (42073)
Australia (6702)
California (5583)
Canada (1823)
China (541)
Colorado (241)
Connecticut (266)
Delaware (143)
Europe (87815)
Florida (839)
Georgia (186)
Idaho (39)
Illinois (497)
India (30)
Indiana (276)
Iowa (10)
Japan (165)
Kansas (97)
Kentucky (20)
Louisiana (9)
Maine (40)
Maryland (850)
Massachusetts (4246)
Michigan (189)
Minnesota (306)
Mississippi (1)
Missouri (73)
Montana (23)
Nebraska (22)
Nevada (53)
New Hampshire (50)
New Jersey (1674)
New Mexico (26)
New York (1642)
North Carolina (931)
North Dakota (9)
Northern California (2429)
Ohio (182)
Oklahoma (15)
Oregon (30)
Pennsylvania (1209)
Puerto Rico (10)
Rhode Island (33)
South America (1097)
South Carolina (16)
South Dakota (1)
Southern California (2132)
Tennessee (91)
Texas (831)
United States (21262)
Utah (162)
Virginia (145)
Washington D.C. (64)
Washington State (542)
West Virginia (2)
Wisconsin (58)
629,685 Results for "hunan tigermed xiangya drug r and d ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tigermed Reports Full Year 2024 Results
March 28, 2025
·
9 min read
IN PARTNERSHIP WITH SMARTLABS
How Modern Vivarium Services Are Revolutionizing Drug Development
In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.
March 24, 2025
·
7 min read
·
BioSpace Insights
Clinical research
Pharma R&D Returns Grow Again, But Deloitte Warns Progress is ‘Fragile’
Deloitte urged pharma executives to “be bold” in a new report tracking the top 20 pharmaceutical companies’ R&D performance.
March 27, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
Tenpoint Therapeutics Ltd. Submits New Drug Application to U.S. FDA for BRIMOCHOL™ PF for the Treatment of Presbyopia
April 8, 2025
·
5 min read
Earnings
Pfizer Announces Another $1.7B in Cost Savings, Including R&D Revamp
Pfizer’s R&D organization has been in flux for almost two years now, since the $43 billion acquisition of ADC specialist Seagen. The new cuts were revealed in the company’s Q1 earnings report.
April 29, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
International Medication Systems, Ltd. Receives FDA’s Drug Shortage Assistance Award
March 31, 2025
·
5 min read
Genetown
NeuroSense Vice President of R&D Shiran Zimri, Ph.D. to Participate in the 3rd Annual ALS Drug Development Summit
NeuroSense Therapeutics Ltd., a company developing novel treatments for severe neurodegenerative diseases, announces that Vice President of R&D, Dr. Shiran Zimri will be a key presenter at the ALS Drug Development Summit in Boston, Mass.
May 20, 2024
·
7 min read
Business
Tigermed Reports Full Year 2023 Results
Hangzhou Tigermed Consulting Co., Ltd., a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its annual results for the year ended December 31, 2023.
March 28, 2024
·
9 min read
Press Releases
Lobe Sciences Ltd. Announces Private Placement to Support Drug Development of Novel Conjugated Psilocin(TM)
April 14, 2025
·
8 min read
Press Releases
Boehringer Ingelheim strengthens antibody-drug conjugate portfolio with new NBE Therapeutics R&D center in Basel
April 3, 2025
·
5 min read
1 of 62,969
Next
